DEFERIPRONE TARO 500 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DEFERIPRONE
Available from:
TARO PHARMACEUTICAL INDUSTRIES LTD
ATC code:
V03AC02
Pharmaceutical form:
TABLETS
Composition:
DEFERIPRONE 500 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
TARO PHARMACEUTICAL INDUSTRIES LTD
Therapeutic area:
DEFERIPRONE
Therapeutic indications:
Deferiprone Tao 500 mg is indicated for the treatment of iron overload in patients over 6 years old with thalassemia major when deferoxamine therapy is contraindicated or inadequate.
Authorization date:
2023-05-15
